Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

@article{Wakabayashi2001AssessmentOU,
  title={Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.},
  author={Toshihiko Wakabayashi and Tomoaki Nakata and Akiyoshi Hashimoto and Satoshi Yuda and Kazufumi Tsuchihashi and Mark I. Travin and Kazuaki Shimamoto},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2001},
  volume={42 12},
  pages={1757-67}
}
UNLABELLED Cardiac (123)I-labeled metaiodobenzylguanidine (MIBG) activity has significant incremental prognostic value, but the difference between the long-term prognostic value of MIBG imaging for ischemic cardiomyopathies and the long-term prognostic value of MIBG imaging for idiopathic cardiomyopathies is not clear. This study aimed to determine whether assessment of cardiac (123)I-MIBG activities in ischemic and idiopathic cardiomyopathies have equally prognostic values and whether the… CONTINUE READING
66 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 66 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Utility of I-123 MIBG imaging and heart rate variability analysis as autonomic markers of sudden death [abstract]. Circulation

  • A Arora, AL Ferrick, T Nakata
  • 2000
3 Excerpts

Utility of I123 MIBG imaging and heart rate variability analysis as autonomic markers of sudden death [ abstract ]

  • A Arora, AL Ferrick, T Nakata
  • 2000

Cardiac death prediction and impaired cardiac sympathetic innervation assessed by metaiodobenzylguanidine in patients with failing and non-failing hearts

  • T Nakata, K Miyamoto, A Doi
  • J Nucl Cardiol
  • 1998
9 Excerpts

Similar Papers

Loading similar papers…